May 3, 2023 07:20 AM EDT
Financing

Mor­phic Ther­a­peu­tic fol­lows pos­i­tive da­ta read­out for UC drug with $240M pub­lic of­fer­ing

Katherine Lewin

News Reporter

Mor­phic Ther­a­peu­tic has used a re­cent pos­i­tive topline da­ta read­out to raise cap­i­tal in the form of an un­der­writ­ten pub­lic of­fer­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times